Advisory Committee Meeting
Amendment of Notice Announcement : September 15, 2016 National Mammography Quality Assurance Advisory Committee Meeting
September 15, 2016
- September 15, 2016
|CDRH||September 15, 2016||8:30 a.m. - 4:30 p.m.||Gaithersburg Holiday Inn– Grand Ballroom
2 Montgomery Village Avenue
Gaithersburg, MD 20879
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-N-0001]
National Mammography Quality Assurance Advisory Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
SUMMARY: The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the National Mammography Quality Assurance Advisory Committee. This meeting was announced in the Federal Register of August 5, 2016. The amendment is being made to reflect a change in the ADDRESSES portion of the document. There are no other changes.
FOR FURTHER INFORMATION CONTACT: S.J. Anderson, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1552, Silver Spring, MD 20993-0002, Sara.Anderson@fda.hhs.gov, 301-796-6875, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code MA. Please call the Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 5, 2016 (81 FR 51918), FDA announced that a meeting of the National Mammography Quality Assurance Advisory Committee would be held on September 15, 2016. On page 51919, in the first column, in the ADDRESSES portion: Hilton Washington, DC/North, Salons A, B, C and D, 620 Perry Pkwy., Gaithersburg, MD 20877. The hotel’s telephone number is 301-977-8900, is changed to read as follows: Gaithersburg Holiday Inn--Grand Ballroom, 2 Montgomery Village Ave., Gaithersburg, MD 20878. The hotel’s telephone number is 301-948-8900.
This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: August 17, 2016.
Janice M. Soreth,
Acting Associate Commissioner,
Special Medical Programs.
A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s website or call the committee’s Designated Federal Officer (see Contact Information) to learn about possible modifications before coming to the meeting.
Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact the committee’s Designated Federal Officer (see Contact Information) at least 7 days in advance of the meeting.
Answers to commonly asked questions including information regarding special accommodations due to a disability may be accessed at: Common Questions and Answers about FDA Advisory Committee Meetings.
FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at Public Conduct During FDA Advisory Committee Meetings for procedures on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2).